Clinical Evidence Regarding Spermidine–Hyaluronate Gel as a Novel Therapeutic Strategy in Vestibulodynia Management

Clinical Evidence Regarding Spermidine–Hyaluronate Gel as a Novel Therapeutic Strategy in Vestibulodynia Management

<b>Background:</b> Vestibulodynia (VBD) represents a summation and overlapping of trigger factors (infections, hormonal disturbances, allergies, genetic aspects, psychological vulnerability, and others) with broad individual variability. As there are no standard treatment options for VBD...

Full description

Saved in:
Bibliographic Details
Main Authors: Filippo Murina, Alessandra Graziottin, Nicla Toni, Maria Teresa Schettino, Luca Bello, Alessandra Marchi, Barbara Del Bravo, Dania Gambini, Lara Tiranini, Rossella Elena Nappi
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pharmaceutics
Subjects:
vulvodynia
vestibulodynia
spermidine
dyaspareunia
Online Access:https://www.mdpi.com/1999-4923/16/11/1448
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1999-4923/16/11/1448

Similar Items